Jenny Brändstedt

Medicine & Life Sciences

1. Ovarian Epithelial Carcinoma 100%
2. Colorectal Neoplasms 61%
3. Neoplasms 44%
4. Ovarian Neoplasms 44%
5. beta Catenin 25%
6. Microsatellite Instability 25%
7. RNA-Binding Proteins 20%
8. Cohort Studies 20%
9. Cyclin D1 18%
10. Survival 16%
11. Peritoneal Neoplasms 15%
12. Carcinogenesis 15%
13. Hormones 14%
14. RNA-Binding Motifs 13%
15. Sex Factors 13%
16. Waist-Hip Ratio 12%
17. alpha-2-HS-Glycoprotein 12%
18. Oral Contraceptives 12%
19. Diet 10%
20. Coenzyme A 10%
21. Cell Cycle Proteins 10%
22. Chlamydia trachomatis 9%
23. Hormone Replacement Therapy 9%
24. Machine Learning 9%
25. Prospective Studies 9%
26. Androgen Receptors 9%
27. Cisplatin 8%
28. Androgens 8%
29. Insulin-Like Growth Factor I 8%
30. Sexually Transmitted Diseases 8%
31. Genetic Variation 8%
32. Carcinoma 8%
33. Neoplasm Metastasis 7%
34. Oxidoreductases 7%
35. Logistic Models 7%
36. Ovary 7%
37. Hip 7%
38. Genes 7%
39. Glycoproteins 7%
40. Waist Circumference 7%
41. Anti-Idiotypic Antibodies 7%
42. Recurrence 7%
43. Obesity 6%
44. Mutation 6%
45. Lymph Nodes 6%
46. Weights and Measures 5%
47. Histology 5%
48. Case-Control Studies 5%
49. Breast Density 5%
50. Mucins 5%